Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
01/19/1994 | EP0578733A1 Use of riboflavin in the treatment of hiv, herpes virus, retinitis pigmentosa and malaria related deseases |
01/19/1994 | CN1080930A Histamine derivatives and methods for their use as immunomodulators |
01/19/1994 | CN1080922A Heterocyclic compounds |
01/19/1994 | CN1080852A Dosage aerosols containing the active substance flezelastin and related structures |
01/18/1994 | US5280125 Chemical process for the preparation of 3-alkylated indole |
01/18/1994 | US5280039 Containing indole and benzene ring structure |
01/18/1994 | CA1326237C Therapeutic nucleosides |
01/16/1994 | CA2100626A1 4-aminoquinazoline derivatives |
01/16/1994 | CA2100412A1 Glycolipid derivatives |
01/16/1994 | CA2099819A1 Ester derivatives |
01/16/1994 | CA2099294A1 N-substituted anilines |
01/12/1994 | EP0578521A1 New peptide derivatives with bradykinin-antagonistic activity, process to prepare them and pharmaceutical compositions containing them |
01/12/1994 | EP0578511A1 Spirooxathiolane-quinuclidine derivative, for treating Sjoegren syndrome |
01/12/1994 | EP0578293A1 E-coli P-fimbrine as immunogenic carrier system against GnRH |
01/12/1994 | EP0578278A1 Uses of IL-1 alpha |
01/12/1994 | EP0529003B1 IgG-BINDING PROTEIN |
01/12/1994 | EP0463101B1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
01/12/1994 | EP0423269B1 Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases |
01/12/1994 | EP0422109B1 Reduction of cell proliferation and enhancement of nk-cell activity |
01/11/1994 | US5278332 Ethers of myoinsitol phosphate for drugs or foods |
01/11/1994 | US5278183 Method for the treatment of autoimmune diseases |
01/11/1994 | US5277907 Regulation of the immune system |
01/11/1994 | CA2481110A1 Vitaletheine and use in cell culture and therapy |
01/11/1994 | CA1326034C Thiazole derivative and leukotriene antagonist containing the same as the effective ingredients |
01/11/1994 | CA1326030C Cyclohept[b]indolealkanoic acids |
01/11/1994 | CA1326029C 4-thiazolidine-carboxylic acid derivative, its preparation and pharmaceutical compositions containing it |
01/11/1994 | CA1326020C Pharmaceutically useful michaels' addition products of unsaturated aldehydes and ketones with ascorbic acid |
01/11/1994 | CA1325973C Cyclosporin-containing pharmaceutical composition |
01/06/1994 | WO1994000571A1 Soluble cr1 derivatives |
01/06/1994 | WO1994000555A2 Compositions for the inhibition of protein hormone formation and uses thereof |
01/06/1994 | WO1994000444A1 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
01/06/1994 | WO1994000437A1 Pharmaceutical pyridine compounds |
01/06/1994 | WO1994000429A1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs |
01/06/1994 | WO1994000428A1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs |
01/06/1994 | WO1994000148A1 Synthetic peptides for the treatment of myasthenia gravis |
01/06/1994 | WO1994000116A1 Agent with adaptogenic activity |
01/06/1994 | WO1992009573A3 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
01/06/1994 | CA2139127A1 Compositions for the inhibition of protein hormone formation and uses thereof |
01/06/1994 | CA2138989A1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs |
01/06/1994 | CA2138954A1 Pharmaceutical pyridine compounds |
01/06/1994 | CA2116575A1 Adaptogenic agent |
01/05/1994 | EP0577544A1 Novel cyclosporins having modifications at position 1 |
01/05/1994 | EP0577025A2 Angiotensin-II-receptorantagonist for the treatment and prophylaxis of coronary heart diseases |
01/05/1994 | EP0576974A1 Benzyliden-quinuclidinones as sunscreen agents |
01/05/1994 | EP0576619A1 1,2-dithiole-3-thione derivative-based therapeutical compositions. |
01/05/1994 | DE4228493C1 Kurbeltrieb für einen Scheibenwischerantrieb eines Kraftfahrzeugs Crankshaft for a windshield wiper drive a motor vehicle |
01/05/1994 | DE4221961A1 22-En-25-oxa-Derivate in der Vitamin D-Reihe, Verfahren zu ihrer Herstellung, diese Derivate enthaltenen pharmazeutische Präparate sowie deren Verwendung als Arzneimittel 22-Ene-25-oxa derivatives in the vitamin D series, process for their preparation, these derivatives contained pharmaceutical preparations and their use as medicaments |
01/05/1994 | DE4220757A1 Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln Derivatives in the vitamin D series with modifications in the 20-position, processes for their preparation, intermediates for this process, pharmaceutical preparations containing these derivatives and their use for the preparation of medicaments |
01/05/1994 | CN1080286A New aminocarboxylic acid derivatives with antiallergic/antiasthmatic effect and a process for their |
01/04/1994 | US5276494 High-speed printing device having a particle trap arranged in the paper channel |
01/04/1994 | US5276057 L-deprenyl for treating immune system dysfunction |
01/04/1994 | US5276037 Antiinflammatory agents, antiallergens |
01/04/1994 | US5276013 Conjugates of biologically stable polyfunctional molecules and polynucleotides for treating systemic lupus erythematosus |
01/04/1994 | US5275817 Physiologically active kanglemycin C |
01/04/1994 | CA1325811C Norbornane derivatives, process for their preparation, and cosmetic and pharmaceutical compositions containing them |
01/04/1994 | CA1325809C Phenylene furyl, and thienyl leukotriene b_ analogues |
01/02/1994 | CA2099447A1 Angiotensin ii receptor antagonists for the treatment and prophylaxis of coronary heart disease |
01/02/1994 | CA2095487A1 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists |
12/29/1993 | EP0576357A1 Pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them |
12/29/1993 | EP0575537A1 Soluble cd28 proteins and methods of treatment therewith |
12/29/1993 | EP0575500A1 Hiv protease inhibitors |
12/29/1993 | EP0575494A1 Leukotriene antagonists |
12/29/1993 | EP0575482A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
12/29/1993 | EP0575454A1 Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof. |
12/29/1993 | EP0375743B1 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
12/29/1993 | CN1079908A Histamine derivatives and methods for their use as immunomodulators |
12/28/1993 | US5274118 Reduction and hydrogenolysis of a diastereomeric butyramide |
12/28/1993 | US5273999 Carboxylic acid leukotriene B4 antagonists |
12/28/1993 | US5273979 Rapamycins; preventing transplant rejection |
12/28/1993 | US5273960 High purity crystalline peptides arglysasp and arglysaspval and a process for their preparation |
12/28/1993 | US5273747 Commiphora mukul extracts and therapeutical applications thereof |
12/28/1993 | CA1325695C Peptides with pharmaceutical activity |
12/28/1993 | CA1325591C Method for treating malignancy and autoimmune disorders in humans |
12/23/1993 | WO1993025667A1 D-enzyme compositions and methods of their use |
12/23/1993 | WO1993025582A1 A novel endothelial cell molecule mediating lymphocyte binding in man |
12/23/1993 | WO1993025575A1 Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus |
12/23/1993 | WO1993025572A1 T-cell monocyte inducing proteins (tmips) |
12/23/1993 | WO1993025530A2 Vinyl arenas having retinoid-like activity |
12/23/1993 | WO1993025517A1 Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors |
12/23/1993 | WO1993025232A1 The use of hyperimmune milk to increase longevity |
12/23/1993 | WO1993025206A1 ORALLY ADMINISTRABLE COMPOSITION OF PYRIDO[1,2-a]PYRIMIDINE DERIVATIVE |
12/23/1993 | CA2137819A1 Vinyl arenas having retinoid-like activity |
12/23/1993 | CA2136641A1 The use of hyperimmune milk to increase longevity |
12/23/1993 | CA2135397A1 T-cell membrane inducing factors |
12/22/1993 | EP0574955A1 Production and use of IL-6 |
12/22/1993 | EP0574906A2 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing the same |
12/22/1993 | EP0574774A1 Substituted benzothiazolyl- and quinoxalyl methoxy-phenyl acetic acid derivatives |
12/22/1993 | EP0574512A1 Redirection of cellular immunity by receptor chimeras |
12/22/1993 | CN1079739A 四氢噻吩衍生物 Tetrahydrothiophene derivative |
12/21/1993 | US5272151 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances |
12/21/1993 | US5272147 Pyrazolopyrimidinone antianginal agents |
12/21/1993 | CA1325431C Di-t-butylphenols substituted by an alkoxy or benzyloxy group or a benzylthio group |
12/21/1993 | CA1325430C Di-t-butylphenyl alkyl and benzyl ethers |
12/19/1993 | CA2098655A1 Bradykinin antagonist peptidic derivatives, process for preparing them and phamaceutical compositions containing same |
12/18/1993 | CA2098562A1 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing the same |
12/18/1993 | CA2098366A1 Substituted (benzothiazolyl- and quinoxalyl-methoxy) phenyl-acetic acid derivatives |
12/15/1993 | EP0574029A1 Recombinant DNA molecules |
12/15/1993 | EP0573977A2 Novel estradiol derivative-chlorambucil conjugate, process for preparing the same, and pharmaceutical composition |
12/15/1993 | EP0573545A1 Monoclonal antibodies against receptor-induced binding sites |
12/15/1993 | EP0573527A1 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans |